Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer-Reference-Cited by-同舟云学术

Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer

Published:2022-01 Issue: Volume:161 Page:90-98
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Randon Giovanni,Intini Rossana,Cremolini Chiara,Elez Elena,Overman Michael J.,Lee Jeeyun,Manca Paolo^ORCID,Bergamo Francesca,Pagani Filippo,Antista Maria,Angerilli Valentina^ORCID,Ros Montaña Francisco Javier^ORCID,Lavacchi Daniele,Boccaccino Alessandra^ORCID,Fucà Giovanni,Brich Silvia,Cattaneo Laura,Fassan Matteo,Pietrantonio Filippo^ORCID,Lonardi Sara^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Encorafenib, binimetinib, and cetuximab in;Kopetz;N Engl J Med,2019

2. Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer;Kopetz;J Clin Oncol,2015

3. The consensus molecular subtypes of colorectal cancer;Guinney;Nat Med,2015

4. BRAF V600E mutant colorectal cancer subtypes based on gene expression;Barras;Clin Cancer Res,2017

5. A phase Ib dose-escalation study of encorafenib and cetuximab with or without alpelisib in metastatic BRAF-mutant colorectal cancer;van Geel;Cancer Discov,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive molecular profiling identifies actionable biomarkers for patients from Thailand and the United Arab Emirates with advanced malignancies;Frontiers in Oncology;2024-05-10

2. Exploring the molecular mechanisms network of breast cancer by multi‐omics analysis;Asia-Pacific Journal of Clinical Oncology;2024-03-13

3. New clinical trial design in precision medicine: discovery, development and direction;Signal Transduction and Targeted Therapy;2024-03-04

4. Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers;Receptors;2024-03-04

5. The BEETS (JACCRO CC-18) trial: an observational and translational study of BRAF-mutated metastatic colorectal cancer;Future Oncology;2023-06